A median of 11 cores (CD3 range 4–16, CD8 range 4–17) was required for >80% of estimated TIL burdens to fall within 20% of the ‘true’ CD3+ or CD8+ TIL burden for the corresponding tumour (Fig. 3D). The gene discussed is CD8A; the disease is neoplasm.